+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Thrombectomy Devices Market - Global Forecast 2026-2032- Product Image
Thrombectomy Devices Market - Global Forecast 2026-2032- Product Image
Sale

Thrombectomy Devices Market - Global Forecast 2026-2032

  • Report

  • 180 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 5012991
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Thrombectomy Devices Market is projected to reach USD 3.50 Billion in 2026. It is expected to continue growing at a CAGR of 7.81%, reaching USD 5.52 Billion by 2032.

Thrombectomy devices are central to modern acute ischemic stroke care because they can physically remove large-vessel occlusions and restore cerebral blood flow when used in the right patient at the right time. Evidence from randomized trials and pooled analyses has established endovascular thrombectomy as standard of care for eligible anterior-circulation large-vessel occlusion, with guideline-supported treatment windows extending to 24 hours in selected patients based on advanced imaging.

The thrombectomy devices landscape is shaped by rising stroke burden, expanding comprehensive stroke center networks, improvements in stent retrievers and aspiration catheters, and growing use of perfusion imaging to identify salvageable brain tissue. Device manufacturers, hospitals, and health systems are competing on speed, reperfusion quality, safety, and workflow integration rather than device mechanics alone.

Transformative Shifts in the Thrombectomy Landscape

The thrombectomy devices landscape is shifting from a device-only market to an integrated stroke systems market. Hospitals increasingly evaluate thrombectomy platforms alongside neuroimaging, transfer protocols, stroke team activation, anesthesia pathways, and post-procedure outcome tracking, because door-to-puncture and reperfusion times directly influence disability outcomes.

Technology is also moving toward larger-bore aspiration systems, improved catheter trackability, combined stent retriever-aspiration techniques, and device designs that support first-pass effect. At the same time, reimbursement pressure and value-based care are pushing suppliers to demonstrate measurable improvements in workflow efficiency, recanalization performance, complication reduction, and total episode-of-care economics.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative effect across the thrombectomy pathway by accelerating large-vessel occlusion detection, supporting perfusion assessment, prioritizing emergency notifications, and coordinating transfers between primary stroke centers and thrombectomy-capable hospitals. Regulated AI stroke imaging tools have been adopted by many stroke networks to reduce diagnostic delays, standardize triage, and help clinicians identify patients who may benefit from endovascular thrombectomy.

AI does not replace clinical judgment, but it improves the consistency of time-critical decisions. The strongest near-term opportunity is the integration of AI alerts, imaging review, electronic health records, cath lab readiness, ambulance coordination, and outcomes registries into a single operational workflow that helps teams identify eligible patients faster and measure real-world performance more reliably.

Key Regional Insights: Asia-Pacific, North America, Europe, and Emerging Regions

North America remains a leading region for thrombectomy devices due to mature stroke center certification, strong neurointerventional capacity, broad adoption of computed tomography angiography and perfusion imaging, and established clinical pathways for large-vessel occlusion stroke. Europe shows sustained demand through national and regional stroke networks, guideline-aligned care pathways, and high use of aspiration and stent retriever technologies, although access can vary by country, reimbursement structure, and hospital tier.

Asia-Pacific is the fastest-changing opportunity area as China, India, Japan, South Korea, and Australia expand neurovascular infrastructure, improve emergency stroke triage, and increase adoption of advanced imaging in tertiary hospitals. Latin America is advancing through centers of excellence in Brazil and Mexico, but uneven reimbursement, limited specialist availability outside major cities, and inter-hospital transfer times remain barriers. The Middle East, led by high-investment health systems in Gulf countries, is expanding comprehensive stroke services, digital emergency coordination, and specialist training, while Africa remains underpenetrated due to limited neurointerventional workforce, imaging access, emergency transport coverage, and concentration of thrombectomy services in a small number of urban referral centers.

Key Group Insights: ASEAN, GCC, EU, BRICS, G7, and NATO

Within ASEAN, demand for thrombectomy devices is rising as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines invest in stroke-ready hospitals, public awareness, and emergency referral systems, though access remains concentrated in urban centers and tertiary institutions. GCC countries are building advanced neurovascular programs through public health investment, specialist recruitment, high-end imaging deployment, and digital emergency care coordination, supporting faster identification and transfer of eligible thrombectomy patients.

The European Union benefits from harmonized clinical guidance, structured procurement systems, cross-border clinical collaboration, and an expanding base of certified stroke centers. BRICS countries represent large-volume clinical opportunity because of high stroke incidence, population scale, and rapid hospital modernization, but reimbursement, device affordability, and specialist availability differ widely across members. G7 markets continue to define clinical benchmarks for thrombectomy workflow, imaging selection, safety reporting, and post-market evidence, while NATO-aligned countries often benefit from emergency response modernization, cross-border training, and resilient medical supply chain planning that can support time-critical stroke intervention.

Key Country Insights Across Major Thrombectomy Markets

The United States leads in thrombectomy procedure volume, technology adoption, clinical research activity, and AI-enabled stroke triage, supported by comprehensive stroke center networks and established reimbursement mechanisms. Canada emphasizes regionalized stroke systems, telestroke, and transfer coordination across large geographies, while Mexico and Brazil are expanding access through large urban hospitals, public-private investment, and growing specialist capabilities in major metropolitan areas.

In Europe, the United Kingdom, Germany, France, Italy, and Spain have mature thrombectomy programs supported by national stroke strategies, established imaging pathways, and trained neurointerventional teams, with Germany and France particularly strong in procedural capacity and specialist infrastructure. Russia has major metropolitan capabilities but uneven regional access caused by geography and variability in hospital resources. China is scaling rapidly through hospital infrastructure expansion and national stroke center development, India is growing from a large unmet-need base with increasing tertiary hospital adoption, Japan and South Korea combine advanced imaging with high device quality expectations and aging-population stroke demand, and Australia benefits from coordinated stroke networks across major cities despite geographic distance and transfer-time challenges.

Actionable Recommendations for Thrombectomy Device Leaders

Industry leaders should prioritize clinical evidence generation, faster workflow integration, and differentiated device performance. The most defensible strategies include demonstrating first-pass reperfusion, lowering distal embolization risk, improving navigation in tortuous anatomy, supporting combined aspiration-stent retriever procedures, and ensuring device compatibility across commonly used access systems.

Commercial teams should align with hospital stroke-network goals by offering physician training, simulation, protocol support, data dashboards, and AI-compatible workflow integration. Manufacturers should also localize market access strategies, strengthen distributor education in emerging regions, support regional centers of excellence, and build post-market evidence that connects device use with functional outcomes, length of stay, complication rates, and cost efficiency.

Research Methodology

This executive summary is developed using a structured secondary research approach that synthesizes guideline-based stroke care evidence, peer-reviewed thrombectomy trial data, regulatory signals, hospital adoption patterns, and regional health system indicators. Core evidence sources include published clinical trials, stroke association guidelines, public regulatory databases, national stroke care frameworks, hospital certification criteria, and reputable health statistics from national and international authorities.

Insights are validated through triangulation across clinical, commercial, regulatory, and policy sources. The methodology emphasizes verified market drivers, technology adoption signals, regional access dynamics, care pathway maturity, and measurable workflow factors such as imaging-to-puncture speed, reperfusion quality, complication reduction, and functional outcome tracking rather than unsupported growth claims.

Conclusion

The thrombectomy devices market is entering a more integrated phase in which device innovation, AI-enabled triage, stroke network maturity, procedural training, and evidence-based reimbursement determine competitive advantage. Demand is supported by the global burden of ischemic stroke and by strong clinical evidence showing that timely thrombectomy improves outcomes in eligible large-vessel occlusion patients.

Organizations that combine high-performing thrombectomy devices with workflow tools, clinical education, and region-specific access strategies will be best positioned to improve adoption while advancing patient outcomes. The next phase of competition will reward measurable speed, safety, reperfusion quality, and real-world value across the full acute stroke care pathway.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Thrombectomy Devices Market, by System Type
7.1. Introduction
7.2. Ultrasound-assisted Thrombolysis
7.3. Rotational Embolectomy
7.4. Thrombus Fragmentation
7.5. Rheolytic Embolectomy
7.6. Aspiration Thrombectomy
8. Thrombectomy Devices Market, by Device Component
8.1. Introduction
8.2. Catheters
8.3. Access & Delivery Tools
8.4. Consumables & Procedure Kits
8.5. Ancillary / Support Devices
9. Thrombectomy Devices Market, by End User
9.1. Introduction
9.2. Research & Academic Institutions
9.3. Ambulatory Surgical Centers
9.4. Hospitals
9.5. Specialty Clinics
10. Thrombectomy Devices Market, by Clinical Application
10.1. Introduction
10.2. Peripheral / Venous
10.2.1. Renal / Mesenteric Thrombosis
10.2.2. Pulmonary Embolism (PE)
10.2.3. Deep Vein Thrombosis (DVT)
10.3. Neurovascular
10.3.1. Cerebral Venous Thrombosis
10.3.2. Acute Ischemic Stroke
10.4. Cardiovascular
10.4.1. Peripheral Arterial Thrombosis
10.4.2. Coronary Artery Thrombosis
11. Thrombectomy Devices Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Thrombectomy Devices Market, by Group
12.1. NATO
12.2. G7
12.3. European Union
12.4. BRICS
12.5. ASEAN
12.6. GCC
13. Thrombectomy Devices Market, by Country
13.1. United States
13.2. China
13.3. Germany
13.4. Japan
13.5. India
13.6. United Kingdom
13.7. France
13.8. Canada
13.9. Australia
13.10. Italy
13.11. Brazil
13.12. South Korea
13.13. Mexico
13.14. Russia
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Acandis GmbH
15.3. Anaconda Biomed
15.4. AngioDynamics, Inc.
15.5. Becton, Dickinson and Company
15.6. Boston Scientific Corporation
15.7. Cardinal Health, Inc.
15.8. Control Medical Technology, LLC
15.9. Cook Group Incorporated
15.10. Endocor GmbH
15.11. Inquis Medical
15.12. Johnson & Johnson Services, Inc.
15.13. Kaneka Corporation
15.14. Koninklijke Philips N.V.
15.15. LeMaitre Vascular, Inc.
15.16. Medico's Hirata Inc.
15.17. Medtronic plc
15.18. Meril Life Sciences Pvt. Ltd.
15.19. Merit Medical Systems, Inc.
15.20. NeuroVasc Technologies Inc.
15.21. Nipro Corporation
15.22. Penumbra, Inc.
15.23. Rapid Medical, Inc.
15.24. Stryker Corporation
15.25. Surmodics, Inc.
15.26. Teleflex Incorporated
15.27. Terumo Corporation
15.28. Uniphar Medtech
15.29. VESALIO
15.30. Wallaby Medical Holding, Inc.
List of Figures
FIGURE 1. GLOBAL THROMBECTOMY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL THROMBECTOMY DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL THROMBECTOMY DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL THROMBECTOMY DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL THROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL THROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL THROMBECTOMY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ULTRASOUND-ASSISTED THROMBOLYSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ULTRASOUND-ASSISTED THROMBOLYSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ULTRASOUND-ASSISTED THROMBOLYSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ROTATIONAL EMBOLECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ROTATIONAL EMBOLECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ROTATIONAL EMBOLECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL THROMBUS FRAGMENTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL THROMBUS FRAGMENTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL THROMBUS FRAGMENTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL RHEOLYTIC EMBOLECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL RHEOLYTIC EMBOLECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL RHEOLYTIC EMBOLECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ASPIRATION THROMBECTOMY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL ACCESS & DELIVERY TOOLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL ACCESS & DELIVERY TOOLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL ACCESS & DELIVERY TOOLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CONSUMABLES & PROCEDURE KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CONSUMABLES & PROCEDURE KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL CONSUMABLES & PROCEDURE KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL ANCILLARY / SUPPORT DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL ANCILLARY / SUPPORT DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL ANCILLARY / SUPPORT DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL RESEARCH & ACADEMIC INSTITUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PERIPHERAL / VENOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PERIPHERAL / VENOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL PERIPHERAL / VENOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL RENAL / MESENTERIC THROMBOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL RENAL / MESENTERIC THROMBOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL RENAL / MESENTERIC THROMBOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL PULMONARY EMBOLISM (PE) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL PULMONARY EMBOLISM (PE) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL PULMONARY EMBOLISM (PE) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL DEEP VEIN THROMBOSIS (DVT) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL NEUROVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL NEUROVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL NEUROVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CEREBRAL VENOUS THROMBOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ACUTE ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL CARDIOVASCULAR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL CARDIOVASCULAR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL CARDIOVASCULAR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL PERIPHERAL ARTERIAL THROMBOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL PERIPHERAL ARTERIAL THROMBOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL PERIPHERAL ARTERIAL THROMBOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CORONARY ARTERY THROMBOSIS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CORONARY ARTERY THROMBOSIS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL CORONARY ARTERY THROMBOSIS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 79. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 80. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 81. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 85. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 87. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 88. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 89. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 90. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 91. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 92. EUROPE THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 100. NORTH AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 109. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 111. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 112. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 114. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 115. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 116. AFRICA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 117. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 126. NATO THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 127. NATO THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 128. NATO THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 129. NATO THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 130. NATO THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 131. NATO THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 132. NATO THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 133. NATO THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 134. G7 THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. G7 THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 136. G7 THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 137. G7 THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. G7 THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 139. G7 THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 140. G7 THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 141. G7 THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 147. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 148. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 149. EUROPEAN UNION THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 150. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 151. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 152. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 153. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 155. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 156. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 157. BRICS THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 158. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 160. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 161. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 162. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 164. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 165. ASEAN THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 166. GCC THROMBECTOMY DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 167. GCC THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 168. GCC THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 169. GCC THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 170. GCC THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. GCC THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 172. GCC THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 173. GCC THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 174. GLOBAL THROMBECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 175. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 176. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 177. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 178. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 179. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 181. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 182. UNITED STATES THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 183. CHINA THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 184. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 185. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 186. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 187. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 188. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 189. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 190. CHINA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 191. GERMANY THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 192. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 193. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 194. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 195. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 196. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 197. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 198. GERMANY THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 199. JAPAN THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 200. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 201. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 202. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 203. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 204. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 205. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 206. JAPAN THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 207. INDIA THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 208. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 209. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 210. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 211. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 212. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 213. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 214. INDIA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 215. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 217. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 218. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 219. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 220. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 221. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 222. UNITED KINGDOM THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 223. FRANCE THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 224. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 225. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 226. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 228. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 229. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 230. FRANCE THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 231. CANADA THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 232. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 233. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 234. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 236. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 237. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 238. CANADA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 239. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 240. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 241. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 242. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 243. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 245. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 246. AUSTRALIA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 247. ITALY THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 248. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 249. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 250. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 251. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 252. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 253. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 254. ITALY THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 255. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 257. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 258. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 260. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 261. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 262. BRAZIL THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 263. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 264. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 265. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 266. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 267. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 268. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 269. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 270. SOUTH KOREA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 271. MEXICO THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 272. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 273. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 274. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 276. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 277. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 278. MEXICO THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 279. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 280. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 281. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 282. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 283. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 285. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 286. RUSSIA THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 287. SPAIN THROMBECTOMY DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 288. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY SYSTEM TYPE, 2017-2032 (USD MILLION)
TABLE 289. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY DEVICE COMPONENT, 2017-2032 (USD MILLION)
TABLE 290. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 291. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY PERIPHERAL / VENOUS, 2017-2032 (USD MILLION)
TABLE 293. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY NEUROVASCULAR, 2017-2032 (USD MILLION)
TABLE 294. SPAIN THROMBECTOMY DEVICES MARKET SIZE, BY CARDIOVASCULAR, 2017-2032 (USD MILLION)
TABLE 295. GLOBAL THROMBECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
TABLE 296. GLOBAL THROMBECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Acandis GmbH
  • Anaconda Biomed
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Control Medical Technology, LLC
  • Cook Group Incorporated
  • Endocor GmbH
  • Inquis Medical
  • Johnson & Johnson Services, Inc.
  • Kaneka Corporation
  • Koninklijke Philips N.V.
  • LeMaitre Vascular, Inc.
  • Medico's Hirata Inc.
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems, Inc.
  • NeuroVasc Technologies Inc.
  • Nipro Corporation
  • Penumbra, Inc.
  • Rapid Medical, Inc.
  • Stryker Corporation
  • Surmodics, Inc.
  • Teleflex Incorporated
  • Terumo Corporation
  • Uniphar Medtech
  • VESALIO
  • Wallaby Medical Holding, Inc.

Table Information

Report AttributeDetails
No. of Pages180
PublishedSeptember 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 3.5 Billion
Forecasted Market Value ( USD ) by 2032 $ 5.52 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Percutaneous Mechanical Thrombectomy System Market - Global Forecast 2026-2032 - Product Image

Percutaneous Mechanical Thrombectomy System Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Nitinol Thrombectomy Stent Market - Global Forecast 2026-2032 - Product Image

Nitinol Thrombectomy Stent Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Neurovascular Thrombectomy Devices/Neurothrombectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Neurovascular Thrombectomy Devices/Neurothrombectomy Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From
Thrombectomy Devices Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036) - Product Image

Thrombectomy Devices Market Size, Share & Trends Analysis - Global Opportunity Analysis and Industry Forecast (2026-2036)

  • Report
  • 287 Pages
  • Global
From
Thrombectomy Devices Market Report by Product Type, Application, End User, and Region 2026-2034 - Product Image

Thrombectomy Devices Market Report by Product Type, Application, End User, and Region 2026-2034

  • Report
  • 144 Pages
  • Global
From

About the Thrombectomy Device Market

The Thrombectomy Device market is a subset of the Cardiovascular Devices market. It is composed of medical devices used to remove blood clots from the body, typically from the arteries. These devices are used to treat a variety of conditions, including stroke, deep vein thrombosis, and pulmonary embolism. Thrombectomy devices are typically minimally invasive, and can be used in both open and endovascular procedures. The Thrombectomy Device market is highly competitive, with a variety of companies offering a range of products. Some of the major players in the market include Medtronic, Boston Scientific, Johnson & Johnson, Stryker, and Terumo. Other companies in the market include Merit Medical, Penumbra, and Teleflex. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.